InvestorsHub Logo
Post# of 251306
Next 10
Followers 16
Posts 4650
Boards Moderated 0
Alias Born 08/11/2015

Re: None

Thursday, 08/17/2017 12:40:32 PM

Thursday, August 17, 2017 12:40:32 PM

Post# of 251306
IMUN - Q2 reports were published on Monday.

IMUN posted a GAIN of .00047 per share attributable to common shareholders (book value).

This was the first ever quarter IMUN posted a gain.

They did it on ZERO REVENUE.

How is this possible? To post a gain on zero revenue? Well, in simplest terms, it was due to the elimination of toxic debt (replaced by debt on way more fair terms - which was announced April 12th and 13th). In a little more detail though, the toxic debt contained usury (rates so outstanding that they were illegal interest rates), and either the CEO or CFO had to sign to it also. The company was to incur $5,000 penalties per day on only a $100k loan - and the books incurred this debt for 13 months which works out to about $2M in penalties from a $100k loan that never had to be paid because it was illegal interest rates, obviously.

The speculation (mine at the very least) is that the note was there in the first place as a way to "cook down" the books. Downward market manipulation, rather than upward. The insiders knew the whole time that the company would never have to pay the ridiculous penalties, but the market was "tricked" into thinking that these penalties would have to be incurred. This will of course cause the stock to drop in value (pre - April 12, 2017).

The following post (which is my sticky note as a moderator of the IMUN board) explains what I'm talking about. It BEGINS to explain why I believe IMUN is so incredibly UNDERVALUED (because I speculate the stock has been demoted - a "Dump and Pump" scheme, the opposite of "Pump and Dump").

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133292770

The ONLY thing that will really make this stock move is whenever initial contracts in Nigeria are published. Last announcement on June 12th (in an 8-k) said sales are expected to begin by end of Q3. Whenever contracts are published, if that does ever happen, this stock will sky rocket. In my opinion. How high it goes will depend on what exactly is announced.

The DD is there on low dose naltrexone and on the company. Yes, it is a penny stock, but they are fully reporting on the OTC QB.

I suggest everybody please check it out. A lot of stuff organized well in the IBox. And I'm happy to answer any questions on the IMUN board.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.